Global Oral Anti-Diabetic Drug Market Report By Product (Sulfonylureas, Biguanides, Alpha-Glucosidase Inhibitors, Megalitinides And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026

ID:VMR11210389
January 2020
Report Formats:

As per this study, the Global Oral Anti-Diabetic Drug Market was valued USD XX.X BN (by revenue) in 2019 and is anticipated to reach USD XX.X BN by 2026 with a CAGR of XX%.

Anti-diabetic drug refers to the medications consumed orally that are prescribed to treat diabetes mellitus (type 2). It treats diabetes (type 2) by lowering down the blood sugar level. These are also known as oral hypoglycemic agents or oral antihyperglycemic agents. Oral anti-diabetic drugs are often prescribed as monotherapy but in severe cases, can be given in combination with insulin.

Market Dynamics
 
Rising diabetic patients globally are majorly driving the demand for oral anti-diabetic drugs. Poor eating habits, stressful lifestyle and lack of physical exercise are some of the factors key contributor in the market growth. Rising demand for oral drugs to reduce blood sugar level owing to a convenient alternative to insulin injections are further fueling the market growth. Advancement in technology leading to development of efficient drugs to minimize the rate of diabetes among the population is expected to boost the market. However, the high cost of drugs is expected to hinder the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of oral anti-diabetic drug.
 
Market Segmentation
 
The broad oral anti-diabetic drug market has been sub-grouped into the product. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Product

  • Sulfonylureas
    • Glimepiride
    • Gliclazide
    • Glyburide
    • Others
  • Biguanides
    • Metformin
    • Others
  • Alpha-Glucosidase Inhibitors
    • Acarbose
    • Voglibose
    • Others
  • Megalitinides
    • Repaglinide
    • Netaglinide
  • Others
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for oral anti-diabetic drug in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Oral Anti-Diabetic Drug Market By Revenue (USD MN)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the oral anti-diabetic drug market include Abbott, AstraZeneca, Biocon, Eli Lilly and Company, Merck & Co., Inc., Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi and Sun Pharmaceutical Industries Ltd among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Oral Anti-Diabetic Drug  Market
       2.2. Global Oral Anti-Diabetic Drug  Market Snapshot
 
3 . ORAL ANTI-DIABETIC DRUG  – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Oral Anti-Diabetic Drug  Market
       3.3. Market Restraints of Oral Anti-Diabetic Drug  Market
       3.4. Opportunities of Oral Anti-Diabetic Drug  Market
       3.5. Trends of Oral Anti-Diabetic Drug  Market
       3.6. Porter’s Five Force Analysis of Oral Anti-Diabetic Drug  Market
       3.7. Oral Anti-Diabetic Drug  Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Product
           3.7.2 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Oral Anti-Diabetic Drug  Value Chain Analysis
       4.2. Oral Anti-Diabetic Drug  Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Oral Anti-Diabetic Drug  Raw Material Manufactures List
           4.2.3. Price Trend of Oral Anti-Diabetic Drug  Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL ORAL ANTI-DIABETIC DRUG  MARKET ANALYSIS BY PRODUCT
       5.1 Overview by Product
       5.2 Global Oral Anti-Diabetic Drug  Market Analysis by Product
       5.3 Market Analysis of Sulfonylureas by Regions
       5.4 Market Analysis of Biguanides by Regions
       5.5 Market Analysis of Alpha-Glucosidase Inhibitors by Regions
       5.6 Market Analysis of Megalitinides by Regions
       5.7 Market Analysis of Others by Regions
 
6 . GLOBAL ORAL ANTI-DIABETIC DRUG  MARKET ANALYSIS BY GEOGRAPHY
       6.1. Regional Outlook
       6.2. Introduction
       6.3. North America
           6.3.1. Overview
           6.3.2. North America Oral Anti-Diabetic Drug  Market Estimate by Market Segment
           6.3.3. North America Oral Anti-Diabetic Drug  Market Estimate by Country
           6.3.4. United State
           6.3.5. Rest of North America
       6.4. Europe
           6.4.1. Overview
           6.4.2. Europe Oral Anti-Diabetic Drug  Market Estimate by Market Segment
           6.4.3. Europe Oral Anti-Diabetic Drug  Market Estimate by Country
           6.4.4. United Kingdom
           6.4.5. France
           6.4.6. Germany
           6.4.6 Rest of Europe
       6.5. Asia Pacific
           6.5.1. Overview
           6.5.2. Asia Pacific Oral Anti-Diabetic Drug  Market Estimate by Market Segment
           6.5.3. Asia Pacific Oral Anti-Diabetic Drug  Market Estimate by Country
           6.5.4. China
           6.5.5. Japan
           6.5.6. India
           6.5.6. Rest of Asia Pacific
       6.6. Latin America
           6.6.1. Overview
           6.6.2. Latin America Oral Anti-Diabetic Drug  Market Estimate by Market Segment
           6.6.3. Latin America Oral Anti-Diabetic Drug  Market Estimate by Country
           6.6.4. Brazil
           6.6.5. Rest of Latin America
       6.7. Middle East & Africa
           6.7.1. Overview
           6.7.2. Middle East & Africa Oral Anti-Diabetic Drug  Market Estimate by Market Segment
           6.7.3. Middle East & Africa Oral Anti-Diabetic Drug  Market Estimate by Country
           6.7.4. Middle East
           6.7.5. Africa
 
7 . COMPETITIVE LANDSCAPE OF THE ORAL ANTI-DIABETIC DRUG  COMPANIES
       7.1. Oral Anti-Diabetic Drug  Market Competition
       7.2. Partnership/Collaboration/Agreement
       7.3. Merger And Acquisitions
       7.4. New Product Launch
       7.5. Other Developments
 
8 . COMPANY PROFILES OF ORAL ANTI-DIABETIC DRUG  INDUSTRY
       8.1. Company Share Analysis
       8.2. Market Concentration Rate
       8.3. Abbott
           8.3.1. Company Overview
           8.3.2. Financials
           8.3.3. Products
           8.3.4. Recent Developments
       8.4. AstraZeneca
           8.4.1. Company Overview
           8.4.2. Financials
           8.4.3. Products
           8.4.4. Recent Developments
       8.5. Biocon
           8.5.1. Company Overview
           8.5.2. Financials
           8.5.3. Products
           8.5.4. Recent Developments
       8.6. Eli Lilly and Company
           8.6.1. Company Overview
           8.6.2. Financials
           8.6.3. Products
           8.6.4. Recent Developments
       8.7. Merck & Co., Inc.
           8.7.1. Company Overview
           8.7.2. Financials
           8.7.3. Products
           8.7.4. Recent Developments
       8.8. Novartis AG
           8.8.1. Company Overview
           8.8.2. Financials
           8.8.3. Products
           8.8.4. Recent Developments
       8.9. Novo Nordisk A/S
           8.9.1. Company Overview
           8.9.2. Financials
           8.9.3. Products
           8.9.4. Recent Developments
       8.10. Pfizer Inc.
           8.10.1. Company Overview
           8.10.2. Financials
           8.10.3. Products
           8.10.4. Recent Developments
       8.11. Sanofi
           8.11.1. Company Overview
           8.11.2. Financials
           8.11.3. Products
           8.11.4. Recent Developments
       8.12. Sun Pharmaceutical Industries Ltd.
           8.12.1. Company Overview
           8.12.2. Financials
           8.12.3. Products
           8.12.4. Recent Developments
 
9.  IMPACT ANALYSIS OF COVID-19 OUTBREAK
       9.1. Impact Analysis of Covid-19 Outbreak on the Market
           9.1.1. Direct Impact on Production
           9.1.2. Supply Chain and Market Disruption
           9.1.3. Financial Impact on Firms and Financial Markets
       9.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       9.3. Pre V/S Post COVID-19 Market
       9.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
       9.5. COVID-19: Micro and Macro Factor Analysis on the Market
    
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Market Snapshot
  • Drivers of the Global Market Impact Analysis
  • Restraints of the Global Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers 
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19 Market
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on the Market
  • Global Oral Anti-Diabetic Drug  Market Analysis by Product (USD MN)
  • Global Oral Anti-Diabetic Drug  Market Analysis in Sulfonylureas by Geography (USD MN)
  • Global Oral Anti-Diabetic Drug  Market Analysis in Biguanides by Geography (USD MN)
  • Global Oral Anti-Diabetic Drug  Market Analysis in Alpha-Glucosidase Inhibitors by Geography (USD MN)
  • Global Oral Anti-Diabetic Drug  Market Analysis in Megalitinides by Geography (USD MN)
  • Global Oral Anti-Diabetic Drug  Market Analysis in Others by Geography (USD MN)
  • Global Oral Anti-Diabetic Drug  Market by Geography (USD MN)
  • North America Oral Anti-Diabetic Drug  Market Analysis by Product (USD MN)
  • North America Oral Anti-Diabetic Drug  Market Estimate by Country (USD MN)
  • United State Oral Anti-Diabetic Drug  Market Analysis by Product (USD MN)
  • Rest of North America Oral Anti-Diabetic Drug  Market Analysis by Product (USD MN)
  • Europe Oral Anti-Diabetic Drug  Market Analysis by Product (USD MN)
  • United Kingdom Oral Anti-Diabetic Drug  Market Analysis by Product (USD MN)
  • France Oral Anti-Diabetic Drug  Market Analysis by Product (USD MN)
  • Germany Oral Anti-Diabetic Drug  Market Analysis by Product (USD MN)
  • Rest of Europe Oral Anti-Diabetic Drug  Market Analysis by Product (USD MN)
  • Asia Pacific Oral Anti-Diabetic Drug  Market Analysis by Product (USD MN)
  • Asia Pacific Oral Anti-Diabetic Drug  Market Estimate by Country (USD MN)
  • China Oral Anti-Diabetic Drug  Market Analysis by Product (USD MN)
  • Japan Oral Anti-Diabetic Drug  Market Analysis by Product (USD MN)
  • India Oral Anti-Diabetic Drug  Market Analysis by Product (USD MN)
  • Rest of Asia Pacific Oral Anti-Diabetic Drug  Market Analysis by Product (USD MN)
  • Latin America Oral Anti-Diabetic Drug  Market Analysis by Product (USD MN)
  • Latin America Oral Anti-Diabetic Drug  Market Estimate by Country (USD MN)
  • Brazil Oral Anti-Diabetic Drug  Market Analysis by Product (USD MN)
  • Rest of Latin America Oral Anti-Diabetic Drug  Market Analysis by Product (USD MN)
  • Middle East & Africa Oral Anti-Diabetic Drug  Market Estimate by Product (USD MN)
  • Middle East & Africa Oral Anti-Diabetic Drug  Market Estimate by Country (USD MN)
  • Middle East Oral Anti-Diabetic Drug  Market Analysis by Product (USD MN)
  • Africa Oral Anti-Diabetic Drug  Market Analysis by Product (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
  • Research Scope of Oral Anti-Diabetic Drug  Report
  • Market Research Process
  • Market Research Methodology
  • Global Oral Anti-Diabetic Drug  Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Oral Anti-Diabetic Drug  Market Analysis by Product (USD MN)
  • Global Oral Anti-Diabetic Drug  Market Analysis in Sulfonylureas by Geography (USD MN)
  • Global Oral Anti-Diabetic Drug  Market Analysis in Biguanides by Geography (USD MN)
  • Global Oral Anti-Diabetic Drug  Market Analysis in Alpha-Glucosidase Inhibitors by Geography (USD MN)
  • Global Oral Anti-Diabetic Drug  Market Analysis in Megalitinides by Geography (USD MN)
  • Global Oral Anti-Diabetic Drug  Market Analysis in Others by Geography (USD MN)
  • Latin America Oral Anti-Diabetic Drug  Market by Revenue
  • Middle East & Africa Oral Anti-Diabetic Drug  Market by Revenue
  • Recent Development in Oral Anti-Diabetic Drug  Industry
  • Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials